Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study

Demosthenes B Panagiotakosa,*, Christos Pitsavosb, Christina Chrysohooub, Efi Tsetsekoub, Charalambos Papageorgiouc, George Christodoulouc and Christodoulos Stefanadisb

a Department of Dietetics and Nutrition, Harokopio University, Athens, Greece
b First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
c Psychiatric Clinic, School of Medicine, University of Athens, Athens, Greece

Received September 25, 2003; revised January 15, 2004; accepted January 22, 2004 * Corresponding author. 46 Paleon Polemiston St., Glyfada, Attica 166 74, Greece. Tel.: +30-2109603116; fax: +30-2109600719
E-mail address: d.b.panagiotakos{at}usa.net


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 
Background Depression is associated with an increase in cardiovascular disease, but the underlying mechanisms are not well understood. The aim of this study was to examine the associations of depressive symptoms with inflammation and coagulation factors related to cardiovascular risk in persons free of cardiovascular disease.

Methods A random algorithm was developed and stratified by gender–age and multistage sampling was performed during 2001–2002. In this study, we analysed data from 453 men (19–89 years old) and 400 women (18–84 years old). Inflammation markers were C-reactive protein (CRP), serum amyloid A, white blood cell (WBC) and total platelet counts; and coagulation factors including homocysteine and fibrinogen. Depression was assessed with the Zung Self-Rating Depression Scale (ZDRS range 0–100) after validation for the study population. A ZDRS score of 50 or more classified a person as mildly depressive. Statistical adjustments were made for risk factors (age, gender, smoking, diabetes mellitus, and physical activity level).

Results Women had significantly higher scores on the Zung depression scale than men (47±9 vs. 43±10, ). Thus, 21% of men and 27% of women had mild depression, while 4% of men and 6% of women had severe depressive symptomatology. The depression scale correlated positively with C-reactive protein levels (), white blood cell count (), and fibrinogen () in both genders after adjustment for control variables.

Conclusion This study revealed that depression was associated with inflammation and coagulation factors in cardiovascular disease-free people, suggesting a possible pathway leading to an increased frequency of events of coronary heart disease in depressive individuals.

Key Words: Depression • Atherosclerosis • Inflammation • Coagulation


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 
Depression is a disorder that affects a large proportion of the general population worldwide. Several studies have demonstrated that 17–20% of the general population suffer from mild to severe depression. This disorder constitutes a worldwide health problem because it is associated with functional impairment in normal life and at work, poor compliance with medical therapy, and life style risk-factor interventions.1,2 The relationship between depression and other diseases like cancer and coronary heart disease was investigated at the beginning of the 20th century. A number of epidemiological studies indicate a significant relationship between depression and the incidence of cardiac events in healthy and cardiovascular-disease populations.3 Depressive symptoms like hopelessness, fatigue, and demoralised feelings are also associated with the development of disease. The mechanisms responsible for the association of depression with coronary heart disease are unclear. Behavioural, biological, and pathophysiological processes include: association of depression with cardiovascular risk factors such as hypertension, smoking habits, physical inactivity, age, sex, hypercholesterolaemia, socioeconomic status, lower heart rate variability, inflammatory processes, platelet aggregation, and hypercortisolaemia.4–10 The association between depression and inflammation and coagulation processes has rarely been investigated in the past. Some studies have reported that depression has been positively correlated with elevated levels of coagulation factors, pro-inflammatory cytokines (IL 1–6, TNF{alpha}), and leukocytes. The stages of acute coronary syndrome (plaque instability, plaque rupture, thrombosis) are related with psychological factors like depression and stress through neuroendocrine, immune, cell, and haemodynamic processes.11,12

In this study, we sought to evaluate the relationships between depressive symptoms and coagulation and inflammation factors (such as C-reactive protein, serum amyloid A, white blood cell and total platelet counts, as well as homocysteine and fibrinogen) related to cardiovascular risk in healthy men and women from the general population.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 
Study population
The ATTICA study is a health and nutrition survey that is being carried out in the province of Attica (with 78% urban and 22% rural areas), where Athens is a major metropolis. The sampling was random, multistage, and based on the city–gender–age distribution of the province of Attica provided by the National Statistical Service (2001 census). Moreover, only one participant per household was selected. From May 2001 to August 2002, 3355 inhabitants were randomly selected from the above area. Of the initially selected individuals, 2282 (68% participation rate) agreed to participate and give blood samples for biochemical and genetic analyses, as well as all the socio-demographic, life style, and medical information requested, including the psychological evaluation. All subjects enrolled in the study were free of clinical evidence of cardiovascular or any other atherosclerotic disease, as well as chronic viral infections. Moreover, subjects had not had a cold or flu, acute respiratory infection, dental problems, or any type of surgery in the previous week. All people living in institutions were excluded from the sample. A full psychological evaluation was carried out in a random subsample of participants that included 453 men and 400 women. This subsample was selected from the study population according to the following algorithm: in each block (i.e., city–gender–age group) we randomly selected (using a sequence of binary numbers, i.e., 1100101100) 1 out of every 3 participants. Thus, 853 participants were finally selected and underwent a detailed psychological evaluation by a group of specialists. The selected subsample can be considered representative of the study population, as well as of the general population, since there were only minor, insignificant differences in sex and age distribution between the study population and the target population. All participants were interviewed by trained personnel, such as cardiologists, dieticians, and nurses, who used a standard questionnaire.

Assessment of depression
Depressive symptomatology was assessed using a translated and validated version of the Zung Self-Rating Depression Scale (ZDRS).13 The ZDRS is a well-known self-rating scale used worldwide for the measurement of depression. It is a self-reporting instrument and was originally developed to assess depression symptoms without the bias of an administrator affecting the results. Higher scores on this scale are indicative of more severe depression.13 The ZDRS consists of 20 items covering affective, psychological, and somatic symptoms. The patient specifies the frequency with which the symptom is experienced (a little=1, some=2, a good part of the time=3, or most of the time=4). A subject with a ZDRS score below 50 is considered normal, a score of 50–59 indicates mild depression, a score of 60–69 indicates moderate depression, and a score of 70 or more is considered to be indicative of severe depression.13

Previous investigations indicate that the ZDRS is a valid and sensitive measure of clinical severity in depressed patients and support its continued use as a research instrument.14 Moreover, the sensitivity of the ZDRS has been found to be adequate14 and the scale was able to significantly differentiate four severity groups classified on the basis of the global rating.

Biochemical measurements
Blood samples were drawn from the antecubital vein between 8:00 and 10:00 a.m., with the subject in a sitting position and after a 12-h fast and alcohol abstinence. The biochemical evaluation was carried out in the same laboratory, which followed the criteria of the World Health Organisation Lipid Reference Laboratories. High-sensitivity C-reactive protein levels, fibrinogen, and serum amyloid A levels were assessed by BNII Dade Behring automatic nephelometry. White blood cell and total platelet counts were made with automated cell counters. Serum total cholesterol was measured using a chromatographic enzymatic method in a Technicon automatic analyser RA-1000. The intra- and interassay coefficients of variation of cholesterol levels did not exceed 9%.

Demographic, clinical, and life style characteristics
The study questionnaire also included demographic information like age, gender, family status (married, divorced, widowed), financial status (average annual income during the past three years), and educational level. The educational level of the participants (as a proxy of social status) was measured by years of schooling and classified into three groups (Group I: <9 years, Group II: up to high school or technical college (10–14 years), and Group III: university).

Information about smoking habits was collected using a standardised questionnaire developed for the study. Current smokers were defined as those who smoked at least one cigarette per day. Never smokers were those who had never tried a cigarette in their lives and former smokers were defined as persons who had stopped smoking more than one year earlier. In all multivariate statistical analyses, cigarette smoking habits were quantified using pack-years (cigarette packs per dayxyears of smoking). However, to correct for the amount of nicotine contained in various types of cigarettes smoked (i.e., light, heavy, very heavy), we assigned a weight to each different type of cigarette pack using 0.8 mg/cigarette as the standard. Physical activity was defined as leisure-time activity of a certain intensity (in kcal/min burned) and duration (minutes per session), at least once a week during the past year, and was graded in qualitative terms such as light (<4 kcal/min burned), moderate (4–7 kcal/min burned), and vigorous (>7 kcal/min burned). The rest of the subjects were defined as physically inactive. Body mass index was calculated as weight (kg) divided by standing height (m2). Obesity was defined as body mass index>29.9 kg/m2.

Arterial blood pressure was measured three times on the right arm (ELKA anaeroid manometric sphygmometer, Von Schlieben Co, West Germany) at the end of the physical examination, after the subject had been in a sitting position for at least 30 min. The systolic blood pressure level was determined by the first perception of sound (of a tapping quality). The diastolic blood pressure level was determined by phase V, when the repetitive sounds become fully muffled (disappear). Changes in loudness were not considered. Patients whose average blood pressure levels were 140/90 mm Hg or more or who were on antihypertensive medication were classified as hypertensives. In addition, for classification purposes hypercholesterolaemia was defined as total serum cholesterol levels greater than 200 mg/dl or the use of lipid-lowering agents, and diabetes mellitus was defined as blood sugar>125 mg/dl or the use of antidiabetic medication. However, in all statistical analyses continuous measurements of blood pressure and chemistries were used.

Consumption of non-refined cereals and products, vegetables, legumes, fruits, olive oil, dairy products, fish, pulses, nuts, potatoes, eggs, sweets, poultry, red meat, and meat products were measured as an average per week during the past year through a validated food-frequency questionnaire from the Department of Nutritional Epidemiology of our institute.15 The frequency of consumption was then quantified approximately in terms of the number of times a month a food was consumed. Alcohol consumption was measured by daily ethanol intake in wineglasses (100 ml and 12% ethanol concentration). Based on the Mediterranean diet pyramid that has been proposed by a Harvard-led team with substantial input from Greek scientists,16 we calculated a special dietary score that assessed adherence to the Mediterranean diet.17 Higher values of this score indicate adherence to the traditional Mediterranean diet (i.e., which is also characterised by moderate consumption of fat and a high monounsaturated:saturated fat ratio), while lower values indicate adherence to a "Westernised" diet.

Since depression affects men and women differently3,4 and several of the biological markers investigated differ between genders,17 we hypothesised that the effect of gender on the depression–inflammation/coagulation relationship may be significant. Thus, we present all the findings separately for men and women.

Details regarding the aims and the design of the ATTICA study have been presented elsewhere.17,18

Statistical analysis
Based on a statistical power calculation (using East 3, 2003, Cytel Software Corporation, USA), we found that the number of participants was adequate to evaluate greater than 0.5 two-tailed standardised differences in the inflammatory and coagulation markers investigated between depression groups. In particular, we achieved a statistical power 0.80 at 0.05 probability level (-value).

Continuous variables are presented as mean values±standard deviation, while qualitative variables are presented as absolute and relative frequencies.

Univariate analysis was initially applied to test the associations between inflammation, coagulation markers (outcome), and ZDRS score (main effect), as well as the associations between various characteristics of the participants and both the outcome and main effect of interest. In particular, associations between categorical variables were tested using contingency tables and the calculation of Pearson’s test. Comparisons between normally distributed continuous variables and categorical variables were made using the Student t-test and one-way analysis of variance (ANOVA), after testing for the equality of variances (homoscedacity). However, the association between the ZDRS score and other categorical variables was tested through calculations of the non-parametric Mann–Whitney and Kruskal–Wallis criteria. Correlations between normally distributed continuous variables were evaluated by calculating the Pearson r-coefficient. Correlations between skewed continuous or discrete variables were evaluated using Spearman’s -coefficient. Moreover, the associations between the ZDRS score and the biochemical markers investigated and other continuous variables (age, body mass index, years of education) were performed by calculating the -coefficient.

The associations between inflammation, coagulation markers (dependent variables), and ZDRS score (independent variable) were also tested through multiple linear regression analysis. The results obtained from the regression models are presented as -coefficients and the standard error of the coefficient. The explanatory variables entered in each multivariate model were ZDRS score and (a) the variables that showed a significant association with dependent variables in univariate analysis (at 15% significance level) of food items consumed (because an association with inflammation and coagulation markers has been reported), (b) those associated with ZDRS score, and (c) various first-order interactions with the score. However, it should be mentioned that since lipid-lowering agents have been associated with decreased cholesterol levels and elevated cholesterol levels have been associated with increased levels of inflammatory markers, information about the use of lipid-lowering medications was included as a separate variable in statistical analyses. A backward elimination procedure was applied to all multivariate models (using as the threshold for removing a variable from the models). Normality tests were applied using the Kolmogorov–Smirnov criterion. C-reactive protein and homocysteine levels were log-transformed due to their skewed distributions. The assumptions of linearity for continuous independent variables and constant variance of the standardised residuals were assessed by plotting the residuals against fitted values. We also calculated R2 to determine how well each fitted model predicts the dependent variables.

All reported -values are based on two-sided tests and compared to a significance level of 5%. However, due to multiple significance tests, we used the Bonferroni correction (because the number of comparisons was less than 10) to account for the increase in the Type I error. SPSS 11.0 software (SPSS Inc. 2002, Illinois, USA) was used for all statistical calculations.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 
Table 1 presents demographic, life style, and clinical characteristics of the participating men and women. With the exception of smoking and hypertension status, where men were more likely to be smokers and hypertensives than women, no other statistically significant differences were observed between genders in physical activity status, education levels, body mass index, and the prevalence of hypercholesterolaemia and diabetes mellitus (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1 Characteristics of study participants

 
Depressive symptomatology and demographic, behavioural, and clinical characteristics
Women had significantly higher ZDRS scores than men (47±9 vs. 43±10, ). In addition, the distribution of depression symptomatology differed significantly between men and women (men, normal: 75%, mild to moderate: 21%, and severe: 4% vs. women, normal: 67%, mild to moderate: 27%, and severe: 6%, ). From our data, it could be speculated that 850,000 Greek men and 1.1 million Greek women suffer mild-to-severe depressive symptoms. Furthermore, a decreasing association was observed between the ZDRS score and age in both men (=–0.081) and women (=–0.071) (significance tests are presented in Table 2). The previous finding was reinforced when we used the age-squared term in the correlation coefficient (men, , and women, ). This is consistent with the U-shape distribution of mild-to-severe depression observed by age. In particular, depression was prevalent in 31% of men and 44% of women before the age of 40 and in 45% of men and 50% of women after the age of 70, compared with 20% of middle-aged men and 30% of middle-aged women. Depressive symptomatology was inversely associated with educational status and physical activity level (in men), while a positive association was found with the prevalence of hypertension in both genders (Table 2). However, due to the multiple significance tests (and the inflation of Type I error), only associations between ZDRS score and hypertension status (in both genders), age, years of education, and physical activity status (in men) could be considered significant (using the Bonferroni correction for Type I error).


View this table:
[in this window]
[in a new window]
 
Table 2 Demographic, behavioural, and clinical characteristics by depression status

 
Afterwards, we performed a multivariate regression analysis that used ZDRS score as the dependent variable and gender, age, years of education, financial level, marital status, body mass index, physical activity status, alcohol intake, systolic and diastolic blood pressure, and total cholesterol as independent variables. The previous analysis revealed that the ZDRS score was significantly associated only with gender and years of education. Table 3 illustrates the associations between the aforementioned factors and ZDRS score in the overall population, since no differences between genders were observed in the effect of these factors on the depression scale.


View this table:
[in this window]
[in a new window]
 
Table 3 Results from the multi variate regression model that evaluated the association between ZDRS score and various explanatory cofactors

 
Depressive symptomatology and inflammation markers
There was a dose–response relationship between the severity of depressive symptoms and the expression of inflammatory and coagulation markers. In particular, ZDRS score was positively correlated with C-reactive protein (=0.18, ), white blood cell count (=0.19, ), and fibrinogen levels (=0.21, ) in men, and positively correlated with C-reactive protein (=0.21, ), white blood cell count (=0.20, ), fibrinogen (=0.27, ), and homocysteine levels (=0.12, ) in women. When we classified our population by depression status (normal, moderate, and severe), we observed a 46% increase in C-reactive protein levels between severe and normal men (Table 4). Similarly, an 11% increase in white blood cell counts and a 17% increase in fibrinogen levels were also observed when we compared men with severe depression to normal men. In women, the relative increase in C-reactive protein levels was 57%, the increase in amyloid A was 36%, the increase in white blood cell counts was 11%, and the increase in fibrinogen was 15% (Table 4).


View this table:
[in this window]
[in a new window]
 
Table 4 Inflammation and coagulation factors, by depression status

 
We further analysed several dimensions of the questionnaire that assessed depression levels in our population. We found that symptoms of fatigue (i.e., sleep changes, agitation) were related with higher fibrinogen levels in both genders (men, =0.23, ; and women, =0.11, ). Moreover, pessimism was highly associated with higher C-reactive protein levels in both genders (men, =0.19, , and women, =0.18, ), while hesitation was positively associated with amyloid A levels (men, rho=0.14, and women, =0.19, ).

Because several factors may confound the relationships between ZDRS score and outcome we performed multivariate analyses. Variables also included in the models presented in Table 5 were body mass index, physical activity status, total cholesterol levels, food items consumed, use of lipid-lowering agents and anti-hypertensive medication, as well as pack-years of smoking, since we found that they were more or less closely associated with all the inflammation and coagulation markers investigated (, data not presented in text). We also included age, years of education, and blood pressure levels because they correlated with ZDRS score in the univariate analysis (Table 2). We finally tested for the significance of the interaction terms of ZDRS score with age, gender, years of education, and physical activity status. The results of multivariate analyses are presented separately for men and women since the interaction term between ZDRS score and gender was highly significant (). We found that C-reactive protein, white blood cell counts, and fibrinogen levels were independently associated with ZDRS score even after adjusting for the aforementioned confounders (Table 5).


View this table:
[in this window]
[in a new window]
 
Table 5 Results of a multivariate regression model that evaluated the association between inflammation and coagulation markers and the Zung depression scale

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 
We observed that about one-fourth of the men and one-third of the women had moderate or severe depressive symptoms. Based on these figures, we may assume that approximately 2.0 million Greek adults suffer mild-to-severe depression. We also examined the association between depression and the expression of inflammatory and coagulation markers implicated in the pathogenesis of coronary heart disease. After controlling for several potential confounders, we found that depressive symptoms were significantly associated with elevated levels of C-reactive protein, fibrinogen, and white blood cell counts in a population-based sample without cardiovascular disease. We also observed an inverse and independent association between depression symptoms and the educational status of the participants.

Depression and inflammatory markers
Recent evidence suggests that inflammatory processes favour the development and progression of thrombotic complications of atherosclerosis.7 Elevated levels of inflammatory biomarkers in apparently healthy populations have been shown to have predictive value for future cardiovascular events.8 In past years few studies aimed to assess the relationship between depressive symptomatology and inflammation processes.19–21 Miller et al.20 observed a 40% increase in C-reactive protein and a 36% increase in interleukin-6 levels between depressive and non-depressive adults. Furthermore, similar results were observed in elderly individuals.19 We also found a strong relation between depression and levels of C-reactive protein in both men and women. In particular, compared to non-depressive subjects, men with severe depression had 46% higher C-reactive protein levels while women with severe depression had 57% higher C-reactive protein levels. However, several investigators have related depression with increased smoking habits, body fat, and physical inactivity.19,20 Since smoking, body fat, and physical activity also have a relationship with C-reactive protein levels,18,22,23 it could be hypothesised that they may have a confounding role in the link between depression and inflammatory processes. However, the associations observed remained statistically significant even when we adjusted for several potential confounders like age, body mass index, dietary and smoking habits, as well as physical activity status (Table 5). We expanded the association between depression and inflammation markers by involving white blood cell counts. In particular, we observed that people with significant depressive symptoms had, on average, 11% higher white blood cell counts as compared to normal persons (Table 4). This association remained statistically significant even after adjusting for several potential confounders (Table 5).

It has been suggested that depression promotes systemic inflammation and increases plasma levels of inflammatory cytokines like IL-6 and acute-phase proteins like C-reactive protein.19–21 Cytokine synthesis and release activated the inflammatory response system, provoking neuroendocrine changes that are interpreted by the brain as stressors and induce the hyperactivity of the hypothalamic–pituitary–adrenal axis and contribute to the development of depression.24–27 Primary preinflammatory cytokines (like interleukin 1, TNF-{alpha}) stimulate the production of a secondary preinflammatory cytokine (interleukin-6) that stimulates the production of acute-phase proteins by the liver, such as C-reactive protein and serum amyloid A.26,27 However, in order to claim a causal relationship between inflammatory processes and depression at the population level, much remains to be learned from future investigations in the field of clinical epidemiology.

Depression and coagulation factors
It has also been suggested that depression leads to high levels of acute-phase proteins, like fibrinogen.25 In addition, fibrinogen forms the substrate for thrombin, is essential for platelet aggregation, modulates endothelial function, and promotes smooth-cell proliferation and migration.28 Thus, fibrinogen is involved in atherothrombogenesis and is an important coagulation marker of cardiovascular disease. We observed that both men and women with even mild depressive symptoms had significantly higher fibrinogen levels (Table 4). Men with severe depression had, on the average, 17% higher fibrinogen levels, while women had 15% higher fibrinogen levels compared to non-depressives. However, depression is associated with elevated levels of cardiovascular factors and life style characteristics, like smoking, obesity, sedentary life, and alcohol consumption.1–4 Thus, the effect of depression on fibrinogen levels may be confounded by these life style risk factors. After taking into account several biological and non-biological factors related with health behaviour, like smoking, physical activity, and dietary habits, we confirmed the independent association between depression and fibrinogen levels (Table 5). Furthermore, we observed that one of the components of depressive symptomatology, feelings of fatigue, was positively related with increased fibrinogen levels in both genders.

Von Känel et al.29 suggests that in healthy individuals, acute mental stress simultaneously activates coagulation within a physiological range, but in patients with atherosclerosis and impaired endothelial anticoagulant function, procoagulant responses to acute stressors may outweigh anticoagulant mechanisms. Thus, based on these hypotheses, associations between psychological factors and several coagulation variables related to atherosclerosis may provide a plausible biobehavioural link to coronary artery disease.

At this point, it should be noted that some investigators have reported that there is no association between measures of depressive symptoms and markers of immune activation or inflammatory response.30 They suggest that there are problems of confounding by co-morbidity and other health-compromising behaviours. In our work the only significant confounder that may alter our findings was educational status. In a recent publication from the same study, we reported an inverse association between educational status and several cardiovascular risk factors, including inflammation and coagulation markers.30 These associations were explained mainly by the adoption of an unhealthy life style (including heavy smoking, physical inactivity, obesity, and non-compliance with medication) by individuals with a low educational level. In this study, we observed that people with mild-to-severe depressive symptoms had a lower educational status compared to non-depressives. Thus, low educational status and its consequences may partially explain the relationships observed between inflammatory and coagulation markers and depressive symptoms. However, our findings were independent of the effect of educational status and other life style-related behaviours.

Furthermore, it has been suggested that self-reported questionnaires, like the Zung depression questionnaire, are supposed to be used as screening tools and not as substitutes for an in-depth interview.13 The assessment of depressive symptomatology using these questionnaires may not be as accurate and valid for detecting people with psychological disorders. Thus, the proportion of men and women that were defined as having mild or severe depression may be under- or over-estimated by our study. Nevertheless, the observed associations between depression and inflammatory response may not be affected by the use of self-reported questionnaires. In addition, although we tried to exclude people with viral infections, a small percentage of participants may have had subclinical infections. The latter may influence our findings, in part, because it is possible that fatigue, loss of appetite, insomnia, and even dysphoric mood may be more common in patients with even minor viral infections. In addition, the presence of an infection may affect the levels of the inflammation and coagulation markers investigated.


    Conclusion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 
Our findings indicate that in otherwise healthy adults, depression was associated with a heightened expression of inflammation and coagulation markers implicated in the pathogenesis of cardiac disease. Differences in life style and other demographic characteristics appear to be partially, although not completely, responsible for this relation. However, the underlying mechanisms of this relationship are not clear and fully identified yet. More research in this field will be able to shed light on information and, therefore, pave the way for better interventions, including better diagnosis of depression and assessment of the effects of the duration of symptoms of depression, potentially leading to the reduction of morbidity and mortality among individuals suffering from cardiac diseases.


    Acknowledgments
 
The ATTICA study was supported by research grants from the Hellenic Cardiological Society (HCS2002) and the Hellenic Atherosclerosis Society (HAS2003). The authors thank the field investigators of the ATTICA study: Dr. Natasa Katinioti (physical examination), Dr. Akis Zeimbekis (physical examination), Dr. Spiros Vellas (physical examination), Dr. Dina Masoura (physical examination), Dr. Lambros Papadimitriou (physical examination), as well as the technical team: Dr. Marina Toutouza (senior investigator/biochemical analysis), Ms. Carmen Vasiliadou (genetic analysis), Mr. Manolis Kambaxis (nutritional evaluation), Ms. Konstadina Paliou (nutritional evaluation), Ms. Constadina Tselika (biochemical evaluation), Ms. Sia Poulopoulou (biochemical evaluation), and Ms. Maria Toutouza (database management).


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 

  1. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch. Intern. Med. 2000;160:2101–2107.[Abstract/Free Full Text]
  2. Ziegelstein RC, Fauerbach JA, Stevens SS et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med. 2000;160:1818–1823.[Abstract/Free Full Text]
  3. Ariyo AA, Haan M, Tangen CM et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation. 2000;102:1773–1779.[Abstract/Free Full Text]
  4. Carney RM, Blumenthal JA, Stein PK et al. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104:2024–2028.[Abstract/Free Full Text]
  5. Carney RM, Freedland KE, Miller GE et al. Depression as a risk factor for cardiac mortality and morbidity. A review of potential mechanisms. J. Psychos. Res. 2002;53:897–902.[CrossRef]
  6. Janice K, Kiecolt-Glaser, Ronald Glaser. Depression and immune function. Central pathways to morbidity and mortality. J. Psychos. Res. 2002;53:873–876.[CrossRef]
  7. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143.[Abstract/Free Full Text]
  8. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J. Intern. Med. 2002;252:283–294.[CrossRef][Medline]
  9. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol. Rev. 2000;8:31–39.[CrossRef][Medline]
  10. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J. Am. Coll. Cardiol. 2003;41:37S–42S.[CrossRef]
  11. Gidron Y, Gilutz H, Berger R et al. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc. Res. 2002;56:15–21.[CrossRef][Medline]
  12. Surtees P, Wainwright N, Day N et al. Association of depression with peripheral leukocyte counts in EPIC-Norfolk-role of sex and cigarette smoking. J. Psychosom. Res. 2003;54:303–306.[CrossRef][Medline]
  13. Zung W. A self-rating depression scale. Arch. General Psychiat. 1965;12:63–70.
  14. Biggs JT, Wylie LT, Ziegler VE. Validity of the Zung self-rating depression scale. Br. J. Psychiat. 1978;132:381–385.[Abstract]
  15. Trichopoulou A. From research to education: the Greek experience. Nutrition. 2000;16:528531.
  16. Willett WC, Sacks F, Trichopoulou A et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am. J. Clin. Nutr. 1995;6:1402S1406S.
  17. Pitsavos C, Panagiotakos DB, Chrysohoou C et al. Epidemiology of cardiovascular risk factors, in Greece; Aims, design and baseline characteristics of the ATTICA study. BMC Public Health. 2003;32:9.[CrossRef]
  18. Panagiotakos DB, Pitsavos CH, Chrysohoou C et al. Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the ATTICA study. J. Hypertens. 2003;21:1483–1489.[CrossRef][Medline]
  19. Kop W, Gottdiener J, Tangen C et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 2002;89:419–424.[CrossRef][Medline]
  20. Miller G, Stetler C, Carney R et al. Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Cardiol. 2002;90:1279–1283.[CrossRef][Medline]
  21. Danner M, Kasl S, Abramson J et al. Association between depression and elevated C-Reactive Protein. Psychos. Med. 2003;65:347–356.[CrossRef]
  22. Shah SH, Newby LK. C-Reactive protein: A novel marker of cardiovascular risk. Cardiol. Rev. 2003;11:169–179.[Medline]
  23. Folsom AR, Aleksic N, Catellier D et al. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am. Heart J. 2002;144:233–238.[CrossRef][Medline]
  24. Appels A, Bar FW, Bar J et al. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom. Med. 2000;62:601–605.[Abstract/Free Full Text]
  25. Berk M, Wadee AA, Kuschke RH, O’Neill-Kerr A. Acute phase proteins in major depression. J. Psychosom. Res. 1997;43:529–534.[CrossRef][Medline]
  26. Anisman H, Merali Z. Cytokines, stress and depressive illness: brain–immune interactions. Ann. Int. Med. 2003;35:2–11.
  27. Leonard B. Stress, depression and the activation of the immune system. World J. Biol. Psychiat. 2000;1:17–25.
  28. Koenig W. Fibrinogen in cardiovascular disease: an update. Thromb. Haemost. 2003;8:601–609.
  29. von Känel R, Mills PJ, Fainman C et al. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis. A biobehavioral pathway to coronary artery disease. Psychosom. Med. 2001;63:531–544.[Abstract/Free Full Text]
  30. Steptoe A, Kunz-Ebrecht SR, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol. Med. 2003;33:667–674.[CrossRef][Medline]